Zions Bancorporation, N.A. Horizon Therapeutics Public LTD CO Transaction History

Zions Bancorporation, N.A.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$62.39 - $113.8 $436 - $796	7 New	7 $0
Q2 2022 Aug 05, 2022	SELL	$79.4 - $116.36 $2,143 - $3,141	-27 Reduced 62.79%	16 $1,000
Q1 2022 May 13, 2022	BUY	$86.42 - $109.81 $2,333 - $2,964	27 Added 168.75%	43 $5,000
Q4 2021 Feb 11, 2022	SELL	$98.56 - $119.91 $197 - $239	-2 Reduced 11.11%	16 $2,000
Q3 2021 Nov 10, 2021	BUY	$91.91 - $110.37 $183 - $220	2 Added 12.5%	18 $2,000
Q4 2020 Feb 12, 2021	BUY	$67.0 - $84.39 $1,072 - $1,350	16 New	16 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Zions Bancorporation, N.A., based on Form 13F filings with the SEC.

Stay updated on Zions Bancorporation, N.A. with notifications on news.